Exploring The Anxiolytic and Neurobehavioral Benefits of Serratiopeptidase in Mice | ||
| Journal of Applied Veterinary Sciences | ||
| Article 6, Volume 10, Issue 1, January 2025, Pages 57-63 PDF (311.33 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/javs.2024.330246.1455 | ||
| Authors | ||
| Younes Abdul hameed1; Ahmad Naser* 2 | ||
| 1Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq | ||
| 2Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq. | ||
| Abstract | ||
| Serratiopeptidase exhibits therapeutic efficacy in a variety of disease models; in addition to its ability to mediate anti-inflammatory action, it is also responsible for regulating several biological activities by targeting different signaling pathways. Our study aimed to evaluate the central nervous effect of serratiopeptidase on neurobehavioral activities and to eliminate anxiety manifestations in mice. Male mice were subjected to neurobehavioral tests, including open field, negative geotaxis, head poking, and swimming tests, in addition to methods of screening for antianxiety, such as elevated pulse maze and light-dark box tests, after one hour of serratiopeptidase at 5, 10, and 20 mg/kg orally. Serratiopeptidase at 20 mg/kg produced a significant increase in the number of squares cut and rearing compared to the control group. Serratiopeptidase at 5, 10, and 20 mg/kg resulted in a decrease in the time required to correct the position of mice in comparison with the control group in negative geotaxis, and there was an increase in the number of stockings compared with the control group. Serratiopeptidase (20 mg/kg) significantly increased the duration of time spent in the open arm and significantly decreased the amount of time spent in the closed arm compared with the control group and the light-dark box test. Serratiopeptidase at 20 mg/kg significantly increased the time spent on the light side of mice and significantly decreased the time spent on the dark side. Serratiopeptidase at 20 mg/kg demonstrated superior effects to the group treated with sertraline in reducing anxiety-like behavior in both tests. In conclusion, serratiopeptidase has a stimulatory effect on the central nervous system, and a high dose may produce anxiolytic-like effects. | ||
| Keywords | ||
| Anxiety; Mice; Open field; Serratiopeptidase | ||
| References | ||
|
AL-AWADHI, R. M., KILANY, O. E., ABDALLAH, O. M., NAGUIB, F. M., and NAGEH, H., 2024. Neuroprotective Effects of Grape Seed Extract against Cadmium Toxicity in Broilers. Journal of Applied Veterinary Sciences, 9(3), 86–101. DOI: 10.21608/javs.2024.293367.1344
AL-JUMAA, Z. M., AL-TAEE, S. K., JABER, M. T., and RAHHAWI, A. M., 2024. Histopathological Alteration and Molecular Detection of Gills Rot Fungus in Carp Fish. Journal of Applied Veterinary Sciences, 9(4), 54–59. DOI: 10.21608/javs.2024.301499.1373
AL-SHALCHI, R. F., and MOHAMMAD, F. K., 2024. Adverse neurobehavioral changes with reduced blood and brain cholinesterase activities in mice treated with statins. Veterinary World, 17(1), 82. https://doi.org/10.14202/vetworld.2024.82-88
ALBADRANY, Y. M., NASER, A. S., and HASAN, M. M., 2021. Study the analgesic effect of diclofenac and silymarin coadministration in chicks. Iraqi Journal of Veterinary Sciences, 35(5), 25-31. https://doi.org/10.33899/ijvs.2021.127065.1453
ALBADRANY, Y., and NASER, A., 2020 . Coenzyme Q10 coadministration with diclofenac augmented impaired renal function in broiler chickens (Gallus gallus domesticus). Veterinary World, 13(4), 642. https://doi.org/10.14202/vetworld.2020.642-648
AZZAM, S. M., RAHMAN, A. A. S. A., AHMED-FARID, O. A., EL-WAFA, W. M. A., and SALEM, G. E. M., 2023 . Lipopolysaccharide induced neuroprotective effects of bacterial protease against Alzheimer’s disease in male Wistar albino rats. International Journal of Biological Macromolecules, 230, 123260. https://doi.org/10.1016/j.ijbiomac.2023.123260
BAKARE, A. O., and OWOYELE, B. V., 2021. Bromelain reduced pro-inflammatory mediators as a common pathway that mediate antinociceptive and anti-anxiety effects in sciatic nerve ligated Wistar rats. Scientific Reports, 11(1), 289. https://doi.org/10.1038/s41598-020-79421-9
BASHAR, Q. M., and ALBADRANY, Y. M. 2022. Evaluation of the Antipyretic, Analgesic, and Anti-inflammatory Effects of Pregabalin in Chicks. Egyptian Journal of Veterinary Sciences, 53(3), 323–328. https://doi.org/10.21608/ejvs.2022.131986.1336
BHALLA, S., MEHAN, S., KHAN, A., and REHMAN, M. U., 2022. Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions. Neuroscience and Biobehavioral Reviews, 142, 104896. https://doi.org/10.1016/j.neubiorev.2022.104896
BOURIN, M., and HASCOËT, M., 2003. The mouse light/dark box test. European Journal of Pharmacology, 463(1–3), 55–65. https://doi.org/10.1016/S0014-2999(03)01274-3
BURNE, T. H. J., JOHNSTON, A. N. B., MCGRATH, J. J., and MACKAY-SIM, A., 2006. Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Research Bulletin, 69(1), 74–78. https://doi.org/10.1016/j.brainresbull.2005.10.014
CRAWLEY, J. N. 1999. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research, 835(1), 18–26. https://doi.org/10.1016/S0006-8993(98)01258-X
DHIMAN, A., and PUROHIT, R., 2023. Targeting tachykinin peptides involved in viral infections through in silico approach: Screening the unforeseen potency of serratiopeptidase. Journal of Molecular Liquids, 392, 123504. https://doi.org/10.1016/j.molliq.2023.123504
FC, F., KJP, M., MMM, C., TL, F., BBI, T., and BN, V., 2024. Effects of Aqueous and Ethanolic Extracts of Ginger (Zingiber Officinale) Rhizome on Serum Progesterone Level and Markers of Oxidative Stress in African Giant Rat (Cricetomys Gambianus) in Captivity. Journal of Applied Veterinary Sciences, 9(3), 11-18. DOI: 10.21608/javs.2024.278828.1326
FIRDAUS, Z., KUMAR, D., SINGH, S. K., and SINGH, T. D., 2022. Centella asiatica alleviates AlCl3-induced cognitive impairment, oxidative stress, and neurodegeneration by modulating cholinergic activity and oxidative burden in rat brain. Biological Trace Element Research, 200(12), 5115–5126. https://doi.org/10.1007/s12011-021-03083-5
HOSSEINI, S. B., AZIZI, M., NOJOUMI, S. A., and VALIZADEH, V., 2024. An up-to-date review of biomedical applications of serratiopeptidase and its biobetter derivatives as a multi-potential metalloprotease. Archives of Microbiology, 206(4), 180. https://doi.org/10.1007/s00203-024-03889-6
JADHAV, S. B., SHAH, N., RATHI, A., RATHI, V., and RATHI, A., 2020. Serratiopeptidase: Insights into the therapeutic applications. Biotechnology Reports, 28, e00544. https://doi.org/10.1016/j.btre.2020.e00544
JAGANNATHAN, H., THOTA, A., B. KUMARAPPA, A. K., and KISHORE, G., 2020. A comparative study of aceclofenac versus etoricoxib in the management of acute low back pain in a tertiary care hospital. Journal of Drug Assessment, 9(1), 60–65. https://doi.org/10.1080/21556660.2020.1734008
KENWOOD, M. M., KALIN, N. H., and BARBAS, H., 2022. The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacology, 47(1), 260–275. https://doi.org/10.1038/s41386-021-01109-z
LA-VU, M., TOBIAS, B. C., SCHUETTE, P. J., and ADHIKARI, A., 2020. To approach or avoid: an introductory overview of the study of anxiety using rodent assays. Frontiers in Behavioral Neuroscience, 14, 145. https://doi.org/10.3389/fnbeh.2020.00145
MOHAMMAD, F. K. 1986. Assessment Of Behavioral, Neurochemical And Developmental Effects In Developing Rats Following In Utero Exposure To Non-Teratogenic Levels Of 2, 4-D And 2, 4, 5-T (Herbicides, Ontogeny). 8(5):551-60. PMID: 3785517
MOTZ, B. A., and ALBERTS, J. R., 2005. The validity and utility of geotaxis in young rodents. Neurotoxicology and Teratology, 27(4), 529–533. https://doi.org/10.1016/j.ntt.2005.06.005
NAIK, S., KATARIYA, R., SHELKE, S., PATRAVALE, V., UMEKAR, M., KOTAGALE, N., and TAKSANDE, B., 2023. Nattokinase prevents β-amyloid peptide (Aβ1-42) induced neuropsychiatric complications, neuroinflammation and BDNF signalling disruption in mice. European Journal of Pharmacology, 952, 175821. https://doi.org/10.1016/j.ejphar.2023.175821
NASER, A. S., and ALBADRANY, Y. M., 2024. Evaluation of the therapeutic effects of serratiopeptidase in chicks. Macedonian Veterinary Review, 47(2), 115-122.https://doi.org/10.2478/macvetrev-2024-0021
NASER, A. S., and ALBERIFKANI, N. M., 2023. Assessment of anxiolytic-like effects of acute and chronic treatment of flurbiprofen in murine. Journal of Ideas in Health, 6(1), 814–819. https://doi.org/10.47108/jidhealth.Vol6.Iss1.268
NASER, A., ALBADRANY, Y., and SHAABAN, K. A., 2021 . Methods of Pain Assessment in Chicks as a Model. Egyptian Journal of Veterinary Sciences, 52(2), 241–249. https://doi.org/10.21608/ejvs.2021.64605.1219
OHKUMA, S., and KATSURA, M., 2001. Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS. Progress in Neurobiology, 64(1), 97–108. https://doi.org/10.1016/S0301-0082(00)00041-1
RODGERS, R. J., and DALVI, A., 1997. Anxiety, defence and the elevated plus-maze. Neuroscience and Biobehavioral Reviews, 21(6), 801–810. https://doi.org/10.1016/S0149-7634(96)00058-9
SAHA, S., BUTTARI, B., PANIERI, E., PROFUMO, E., and SASO, L., 2020. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules, 25(22), 5474. https://doi.org/10.3390/molecules25225474
SAXENA, P., SELVARAJ, K., KHARE, S. K., and CHAUDHARY, N., 2022. Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases. Biotechnology Letters, 1–22. https://doi.org/10.1007/s10529-021-03200-3
SCHAPIRO, S., SALAS, M., and VUKOVICH, K., 1970. Hormonal effects on ontogeny of swimming ability in the rat: assessment of central nervous system development. Science, 168(3927), 147–151. https://doi.org/10.1126/science.168.3927.147
STANFORD, S. C. 2007. The open field test: reinventing the wheel. Journal of Psychopharmacology, 21(2), 134–135. https://doi.org/10.1177/0269881107073199
TELEANU, R. I., NICULESCU, A.-G., ROZA, E., VLADÂCENCO, O., GRUMEZESCU, A. M., and TELEANU, D. M., 2022. Neurotransmitters—key factors in neurological and neurodegenerative disorders of the central nervous system. International Journal of Molecular Sciences, 23(11), 5954. https://doi.org/10.3390/ijms23115954
TIWARI, M. 2017. The role of serratiopeptidase in the resolution of inflammation. Asian Journal of Pharmaceutical Sciences, 12(3), 209–215. https://doi.org/10.1016/j.ajps.2017.01.003
YARDIMCI, A., ERTUGRUL, N. U., OZGEN, A., OZBEG, G., OZDEDE, M. R., ERCAN, E. C., and CANPOLAT, S., 2023. Effects of chronic irisin treatment on brain monoamine levels in the hypothalamic and subcortical nuclei of adult male and female rats: An HPLC-ECD study. Neuroscience Letters, 806, 137245. https://doi.org/10.1016/j.neulet.2023.137245 | ||
|
Statistics Article View: 319 PDF Download: 322 |
||
